Question 1

When a pharmacoeconomic analysis looks at two or more treatment alternatives that are considered equal in efficacy and compares the costs of each it is referred to as:

Accepted Answer

A)   Cost-minimization analysis
B)   Cost-of-illness analysis
C)   Cost-effectiveness analysis
D)   Cost-benefit analysisE) C) and D)
F) None of the above

Question 2

Prescribing less-expensive generic drugs or drugs off the $4 retail pharmacy lists:

Accepted Answer

A)   Increases the complexity of the pharmacoeconomics of prescribing for the individual patient
B)   Increases compliance by reducing the financial burden of drug costs to the patient
C)   Is not sound prescribing practice due to the inferiority of the generic products
D)   Will increase the overall cost of drugs to the system due to the ease of overprescribing less-expensive drugsE) A) and D)
F) A) and C) B

Question 3

The "donut hole" in Medicare Part D:

Accepted Answer

A)   Will be totally eliminated with the federal health-care reform enacted in 2010
B)   Refers to the period of time when annual individual drug costs are between $250 and $2,250 per year and drug costs are covered 75%2013) 
C)   Refers to the period between when the annual individual drug costs are $2,970 and $4,750 and the patient pays 52.5% of the costs of brand name drugs (
D)   Has no effect on whether patients continue to fill their prescriptions during the coverage gapE) A) and B)
F) B) and D)

Question 4

James tells you that he is confused by his Medicare Part D coverage plan. An appropriate intervention would be:

Accepted Answer

A)   Order cognitive testing to determine the source of his confusion.
B)   Sit down with him and explain the whole Medicare Part D process.
C)   Refer him to the Medicare specialist in his insurance plan to explain the benefit to him.
D)   Request his son come to the next appointment so you can explain the benefit to him.E) A) and C)
F) All of the above

Question 5

Mary has a two-tiered prescription benefit plan, which means:

Accepted Answer

A)   She can receive differing levels of care based on whether she chooses an "in-plan" provider or not.
B)   She is eligible for the new Medicare Part D "donut hole" reduction of costs program.
C)   She pays a higher copay for brand-name drugs than for generic drugs.
D)   She must always choose to be treated with generic drugs first.E) All of the above
F) A) and D)

Question 6

Research has shown that when patients who are covered by Medicare Part D reach the "donut hole" in coverage they:

Accepted Answer

A)   Ask for extra refills of medication to get them through the months of no coverage
B)   Fill their prescriptions less frequently, including critical medications such as warfarin or a statin
C)   Fill their critical medications, but hold off on filling less-critical medications
D)   Demonstrate no change in their prescription filling patternE) A) and D)
F) A) and B)

Question 7

Pharmacoeconomics is:

Accepted Answer

A)   The study of the part of the U.S. economy devoted to drug use
B)   The study of the impact of prescription drug costs on the overall economy
C)   The analysis of the costs and consequences of any health-care-related treatment or service
D)   The analysis of the clinical efficacy of the drugE) A) and D)
F) A) and B)

Question 8

The intangible costs of drug therapy include:

Accepted Answer

A)   Loss of wages while undergoing therapy
B)   Inconvenience, pain, and suffering incurred with therapy
C)   Cost of medical equipment in the laboratory used to monitor therapeutic drug levels
D)   Cost of prescription drug coverage, such as Medicare Part DE) A) and B)
F) All of the above B

Question 9

The direct costs of drug therapy include:

Accepted Answer

A)   The actual cost of acquiring the medication
B)   The loss of income due to illness
C)   Pain and suffering due to inadequate drug therapy
D)   The cost of a funeral associated with premature deathE) B) and C)
F) A) and D)

Question 10

Cost-effectiveness analysis compares two or more treatments or programs that are:

Accepted Answer

A)   Not necessarily therapeutically equivalent
B)   Considered equal in efficacy
C)   Compared with the dollar value of the benefit received
D)   Expressed in terms of patient preference or quality-adjusted life yearsE) C) and D)
F) B) and C)

Question 11

Indirect costs associated with drug therapy include:

Accepted Answer

A)   The cost of diagnostic tests to monitor therapeutic levels
B)   Health-care provider time to prescribe and educate the patient
C)   Child-care expenses incurred while receiving therapy
D)   Loss of wages while undergoing drug therapyE) B) and D)
F) A) and D)

Question 12

When the costs of a specific treatment or intervention are calculated and then compared with the dollar value of the benefit received it is referred to as:

Accepted Answer

A)   Cost-minimization analysis
B)   Cost-of-illness analysis
C)   Cost-effectiveness analysis
D)   Cost-benefit analysisE) A) and B)
F) A) and D) D

Exam 12: Pharmacoeconomics

When a pharmacoeconomic analysis looks at two or more treatment alternatives that are considered equal in efficacy and compares the costs of each it is referred to as:

Correct Answer
verified

Prescribing less-expensive generic drugs or drugs off the $4 retail pharmacy lists:

Correct Answer
verified
B

The "donut hole" in Medicare Part D:

Correct Answer
verified

James tells you that he is confused by his Medicare Part D coverage plan. An appropriate intervention would be:

Correct Answer
verified

Mary has a two-tiered prescription benefit plan, which means:

Correct Answer
verified

Research has shown that when patients who are covered by Medicare Part D reach the "donut hole" in coverage they:

Correct Answer
verified

Pharmacoeconomics is:

Correct Answer
verified

The intangible costs of drug therapy include:

Correct Answer
verified
B

The direct costs of drug therapy include:

Correct Answer
verified

Cost-effectiveness analysis compares two or more treatments or programs that are:

Correct Answer
verified

Indirect costs associated with drug therapy include:

Correct Answer
verified

When the costs of a specific treatment or intervention are calculated and then compared with the dollar value of the benefit received it is referred to as:

Correct Answer
verified
D

Exam 12: Pharmacoeconomics

When a pharmacoeconomic analysis looks at two or more treatment alternatives that are considered equal in efficacy and compares the costs of each it is referred to as:

Correct AnswerverifiedShow Answer

Prescribing less-expensive generic drugs or drugs off the $4 retail pharmacy lists:

Correct AnswerverifiedB

The "donut hole" in Medicare Part D:

Correct AnswerverifiedShow Answer

James tells you that he is confused by his Medicare Part D coverage plan. An appropriate intervention would be:

Correct AnswerverifiedShow Answer

Mary has a two-tiered prescription benefit plan, which means:

Correct AnswerverifiedShow Answer

Research has shown that when patients who are covered by Medicare Part D reach the "donut hole" in coverage they:

Correct AnswerverifiedShow Answer

Pharmacoeconomics is:

Correct AnswerverifiedShow Answer

The intangible costs of drug therapy include:

Correct AnswerverifiedB

The direct costs of drug therapy include:

Correct AnswerverifiedShow Answer

Cost-effectiveness analysis compares two or more treatments or programs that are:

Correct AnswerverifiedShow Answer

Indirect costs associated with drug therapy include:

Correct AnswerverifiedShow Answer

When the costs of a specific treatment or intervention are calculated and then compared with the dollar value of the benefit received it is referred to as:

Correct AnswerverifiedD

Correct Answer
verified

Correct Answer
verified
B

Correct Answer
verified

Correct Answer
verified

Correct Answer
verified

Correct Answer
verified

Correct Answer
verified

Correct Answer
verified
B

Correct Answer
verified

Correct Answer
verified

Correct Answer
verified

Correct Answer
verified
D